FDA posts laboratory analysis of NDMA levels in recalled valsartan products

As part of its ongoing investigation into the presence of impurities in valsartan products, FDA has released lab test results with NDMA levels in the recalled products.

As part of its ongoing investigation into the presence of impurities in valsartan products, FDA has released lab test results with NDMA levels in the recalled products. In addition, the agency will release the test results and an analysis of the cancer risk from NDEA when they are available.